🔗 Permalink

Inventor profile of:

Stefano Colloca

City:

Rome

Country:

Italy

Published Applications:

39

Last publication date:

2024-03-21

Top Assignees for applications by Stefano Colloca

The entities that hold a legal rights for patent applications filed by inventor Colloca Stefano:

GlaxoSmithKline Biologicals S.A. 26 Rixensart, Belgium
Istituto di Ricerche di Biologia Molecolare P. Angeletti SpA 3 Rome, Italy
MSD Italia S.R.L. 2 Rome, Italy
NOUSCOM AG 2 BASEL, Switzerland
The United States of America as Represented by the Department of Health and Human Services 1 Washington, DC United States
Merck Sharp Dohme Corp. 1 Rahway, NJ United States
Merck & Co., Inc. 1 Rahway, NJ United States
OKAIROS AG 1 Basel, Switzerland
SABIN VACCINE INSTITUTE 1 Washington, DC United States
TheGovernmentof the UnitedStatesof America asRepre -sentedby theSecretaryoftheDept.ofHealth&HumanSer 1 Rockville, MD United States
The Government of the United States of America as Represented by the Secretary of the Department of 1 Rockville, MD United States
GlaxoSmithKline Biologicals SA 1 , Belgium
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services 1 Rockville, MD United States

Recent patent applications by Colloca Stefano

Stefano Colloca from Rome, IT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-03-21

US20240093161A1

Chemistry; metallurgy

Simian adenoviral vectors with two expression cassettes

#2 | 2024-01-04

US20240002879A1

Chemistry; metallurgy

GORILLA ADENOVIRUS NUCLEIC ACID- AND AMINO ACID-SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREOF

#3 | 2023-05-25

US20230158134A1

Human necessities

CHIMPANZEE ADENOVIRUS CONSTRUCTS WITH LYSSAVIRUS ANTIGENS

#4 | 2022-11-17

US20220364115A1

Chemistry; metallurgy

ENHANCED PROMOTER

#5 | 2022-09-01

US20220275397A1

Chemistry; metallurgy

Adenovirus polynucleotides and polypeptides

#6 | 2022-07-14

US20220220157A1

Chemistry; metallurgy

ADENOVIRUS POLYNUCLEOTIDES AND POLYPEPTIDES

#7 | 2022-06-30

US20220204566A1

Chemistry; metallurgy

ADENOVIRUS POLYNUCLEOTIDES AND POLYPEPTIDES

#8 | 2022-04-14

US20220112245A2

Chemistry; metallurgy

CHIMPANZEE ADENOVIRUS CONSTRUCTS WITH LYSSAVIRUS ANTIGENS

#9 | 2022-03-03

US20220064669A1

Chemistry; metallurgy

Chimpanzee adenoviral vector-based filovirus vaccines

#10 | 2021-08-12

US20210246468A1

Chemistry; metallurgy

Simian adenovirus vectors comprising the ChAd-157 fiber protein

#11 | 2021-06-24

US20210189422A1

Chemistry; metallurgy

Adenoviral vectors with two expression cassettes encoding RSV antigenic proteins or fragments thereof

#12 | 2021-06-24

US20210189421A1

Chemistry; metallurgy

Replication competent adenoviral vectors

#13 | 2021-06-24

US20210189420A1

Chemistry; metallurgy

Enhanced promoter

#14 | 2021-05-06

US20210130848A1

Chemistry; metallurgy

Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof

#15 | 2021-03-04

US20210060150A1

Human necessities

NOVEL ADENOVIRUS

#16 | 2020-10-01

US20200308601A1

Chemistry; metallurgy

Eukaryotic cell line

#17 | 2020-09-24

US20200299651A1

Chemistry; metallurgy

SIMIAN ADENOVIRAL VECTORS WITH TWO EXPRESSION CASSETTES

#18 | 2020-05-28

US20200164061A1

Human necessities

Poxviral vaccines

#19 | 2020-05-14

US20200149069A1

Chemistry; metallurgy

CHIMPANZEE ADENOVIRAL VECTOR-BASED FILOVIRUS VACCINES

#20 | 2020-05-07

US20200140886A1

Chemistry; metallurgy

Adenovirus polynucleotides and polypeptides

#21 | 2020-04-02

US20200102352A1

Chemistry; metallurgy

Recombinant simian adenoviral vectors encoding a heterologous fiber protein and uses thereof

#22 | 2019-10-03

US20190300905A1

Chemistry; metallurgy

Adenovirus polynucleotides and polypeptides

#23 | 2018-08-02

US20180216081A1

Chemistry; metallurgy

NOVEL ADENOVIRUS

#24 | 2018-06-21

US20180170972A1

Chemistry; metallurgy

Adenovirus polynucleotides and polypeptides

#25 | 2018-05-10

US20180125968A1

Human necessities

Poxviral vaccines

#26 | 2018-03-01

US20180057540A1

Chemistry; metallurgy

Chimpanzee clade E adenovirus nucleic acid-and amino acid-sequences, vectors containing same, and uses thereof

#27 | 2018-02-20

US12595576

Human necessities

Simian adenoviral vectors encoding malaria antigen

#28 | 2017-11-23

US20170333550A1

Human necessities

Poxviral vaccines

#29 | 2017-02-16

US20170044571A1

Chemistry; metallurgy

Chimpanzee adenoviral vector-based filovirus vaccines

#30 | 2016-01-07

US20160000904A1

Human necessities

IMPROVED POXVIRAL VACCINES

#31 | 2013-04-25

US20130101618A1

Human necessities

Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoprotein

#32 | 2012-12-27

US20120328651A1

Chemistry; metallurgy

Chimpanzee adenovirus vaccine carriers

#33 | 2012-02-02

US20120027788A1

Chemistry; metallurgy

Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof

#34 | 2011-09-08

US20110217332A1

Chemistry; metallurgy

Chimpanzee adenovirus vaccine carriers

#35 | 2009-10-06

US10492178

Hepatitis C virus vaccine

#36 | 2009-09-17

US20090233992A1

Chemistry; metallurgy

Hepatitis C virus vaccine

#37 | 2009-02-05

US20090035277A1

Human necessities

Hepatitis C virus nucleic acid vaccine

#38 | 2007-12-27

US20070298498A1

Chemistry; metallurgy

Adenoviral Amplicon and Producer Cells for the Production of Replication-Defective Adenoviral Vectors, Methods of Preparation and Use Thereof

#39 | 2005-05-10

US9831182

Cells for the production of helper dependent adenoviral vectors

InventorID:

209158 ⎘